Century Therapeutics, Inc. Balance Sheet
IPSC|4 years of annual SEC 10-K data (FY2022-FY2025)
Shows total assets, cash and equivalents, receivables, property and equipment, total debt, and shareholders' equity across 4 fiscal years. All figures from audited SEC 10-K filings.
At a glance
Total Assets
$224M
FY2025
Cash
$62M
Cash and equivalents
Total Debt
N/A
FY2025
Shareholder Equity
$161M
FY2025
Century Therapeutics, Inc. had $224M in total assets and $161M in shareholders' equity as of FY2025.
Based on SEC 10-K filings.
Key Data Points
- Altman Z-Score NaN (distress zone, below 1.23 threshold)
- Currently unprofitable: Net income is negative
- Cash-backed earnings: Operating cash flow exceeds net income
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| Cash & Equivalents | $61.9M | $58.4M | $47.3M | $84.3M |
| Current Assets | $120.8M | $194.1M | $177.0M | $319.7M |
| PP&E (Net) | $50.0M | $62.1M | $71.7M | $82.8M |
| Total Assets | $223.7M | $353.2M | $360.7M | $486.5M |
| Current Liabilities | $20.2M | $129.8M | $17.8M | $29.8M |
| Total Debt | - | - | - | $3.7M |
| Shareholders' Equity | $161.4M | $184.8M | $302.7M | $396.2M |